KOSAN BIOSCIENCES INC
10-Q, EX-27.1, 2000-11-15
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: KOSAN BIOSCIENCES INC, 10-Q, 2000-11-15
Next: EROOMSYSTEM TECHNOLOGIES INC, NT 10-Q, 2000-11-15



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS AS OF AND FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 2000.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           4,923
<SECURITIES>                                     9,570
<RECEIVABLES>                                      169
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                14,757
<PP&E>                                           4,790
<DEPRECIATION>                                   1,659
<TOTAL-ASSETS>                                  35,687
<CURRENT-LIABILITIES>                            3,439
<BONDS>                                          2,300
                                0
                                          4
<COMMON>                                             7
<OTHER-SE>                                      29,937
<TOTAL-LIABILITY-AND-EQUITY>                    35,687
<SALES>                                              0
<TOTAL-REVENUES>                                 3,419
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                15,296
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 261
<INCOME-PRETAX>                               (22,197)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (22,197)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (22,197)
<EPS-BASIC>                                     (4.31)
<EPS-DILUTED>                                   (4.31)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission